Skip to main content
Premium Trial:

Request an Annual Quote

SIRS Lab Ditches In-House Gene-Expression Platform for Illumina System

NEW YORK (GenomeWeb News) — SIRS-Lab has adopted an Illumina gene-expression system for its expression services, and has stopped using the internally developed gene-expression system it had offered over the past five years, according to a company scientist.
“Before we were making our own arrays, but we decided to stop this business,” SIRS-Lab’s Julien Landre told GenomeWeb Daily News sister publication BioArray News this week. “The Illumina platform is new. We’ve been in this business for quite awhile, and when it comes to gene expression, this platform suits us best.”
Customers for Jena, Germany-based SIRS-Lab’s gene-expression service include the William Harvey Research Institute in London and Charité University in Berlin, according to a statement from the company.
SIRS-Lab currently has a separate diagnostic-discovery program focusing on sepsis, but Landre said that the company has not made a decision on what platform it will use for future tests.

This article originally appeared in the current issue of BioArray News, a GenomeWeb Daily News sister publication.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.